tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market
CTNM
Contineum Therapeutics, Inc. Class A
RESEARCH TOOLSreports
Want to see CTNM full AI Analyst Report?

Contineum Therapeutics, Inc. Class A (CTNM) Revenue

212 Followers
StatisticsMarket CapRevenue

Contineum Therapeutics, Inc. Class A Revenue

Contineum Therapeutics, Inc. Class A had a revenue of 0.00 in the quarter ending Dec 31, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Contineum Therapeutics, Inc. Class A had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
41
Market Cap
$502.68M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
―――
Dec 31, 2024
―-50.00M-100.00%
Dec 31, 2023
50.00M―+∞%
Dec 31, 2022
―――
Dec 31, 2021
―――